People who received hernia mesh implants in a hernia repair surgery may have been placed at risk for serious injury.
Several studies show users experienced heart health issues, including heart attacks, after using PPI medications.
According to the lawsuits, the manufacturer hid problems with its joint replacement implants from regulators, and failed to warn consumers and medical professionals about the increased likelihood of failure.
Homeowners with mortgages through JPMorgan Chase Bank, N.A. who participated in the HAMP loan modification program should contact us to discuss their participation in the program.
A security issue was discovered in Intel x86-64x central processing units in 2017 and affects nearly every computer and laptop purchased since 2008, as well as nearly every server installed within that same time period.
This recall is only the most recent issue related to Medtronic MiniMed Insulin Pumps and involves a malfunction of the infusion set used to supply insulin to diabetic patients.
Homeowners living in houses built after December 2016 with TJI Joists have reported the joists give off a strong “pickled” odor.
A large percentage of hip replacement failures have been caused due to the design of certain devices with Metal on Metal (MoM) design.
Concern for the safety of hepatitis C medications is serious enough that the US Food and Drug Administration (FDA) recently issued its strongest warning.
Seeger Weiss, LLP is investigating claims of users of the drug Benicar who developed serious GI issues including but not limited to: excessive weight loss, vomiting, chronic diarrhea, nausea.
Johnson & Johnson’s Ethicon division issued a full withdrawal in May 2016 concerning its Physiomesh Flexible Composite Mesh. The voluntary withdrawal came after two studies found higher rates of hernia re-opening versus similar products.
The U.S. Food and Drug Administration has issued a new safety alert regarding a possible increase in the risk of leg or foot amputation after taking the antidiabetic medication, Invokana.
While many patients taking this medication were under the impression it would help them with their medical issues, reports have emerged that these patients may be at severe risk for injuries and dangerous side effects.
Recent research studies have shown an increase in the risk of chronic kidney disease for individuals who take this PPI medication.
In 2015, an FDA panel required that AstraZeneca place an additional warning about Onglyza on the label that would warn patients about a potential risk of heart failure.
Complaints about the IVC filters began to surface as early as 2004, but the company continued to sell the devices and did not notify the FDA of complaints or device failures.
In 2014, the Food and Drug Administration released a safety announcement warning, telling customers about the potential risks of testosterone therapy.
Johnson and Johnson and Bayer AG are currently in the process of settling approximately one dozen lawsuits associated with the blood thinning medication Xarelto.
Investigations have now revealed that Conceptus and Bayer likely knew of the issues with Essure, but failed to warn doctors and users of the device.
People who received hernia mesh implants in a hernia repair surgery may have been placed at…